Basit öğe kaydını göster

Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-alpha Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence

dc.contributor.authorDalkilic, Ediz
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorKILIÇ, LEVENT
dc.contributor.authorErtenli, Ihsan
dc.contributor.authorDireskeneli, Haner
dc.contributor.authorKeser, Gokhan
dc.contributor.authorOzguler, Yesim
dc.contributor.authorErer, Sait Burak
dc.contributor.authorOksel, Fahrettin
dc.contributor.authorOnat, Ahmet Mesut
dc.contributor.authorYILMAZ, Sedat
dc.contributor.authorPAY, Salih
dc.contributor.authorBalkarli, Ayse
dc.contributor.authorCobankara, Veli
dc.contributor.authorCetin, Gode Yildirim
dc.contributor.authorSayarlioglu, Mehmet
dc.contributor.authorCefle, Ayse
dc.contributor.authorYazici, Ayten
dc.contributor.authorAVCI, Ali Berkant
dc.contributor.authorTerzioglu, Ender
dc.contributor.authorOzbek, Suleyman
dc.contributor.authorAkar, Servet
dc.contributor.authorKisacik, Bunyamin
dc.contributor.authorPamuk, Omer Nuri
dc.contributor.authorGul, Ahmet
dc.contributor.authorHatemi, Gulen
dc.contributor.authorCan, Meryem
dc.date.accessioned2021-03-05T18:01:09Z
dc.date.available2021-03-05T18:01:09Z
dc.date.issued2016
dc.identifier.citationKisacik B., Pamuk O. N. , Onat A. M. , Erer S. B. , Hatemi G., Ozguler Y., Pehlivan Y., KILIÇ L., Ertenli I., Can M., et al., "Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-alpha Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence", JOURNAL OF RHEUMATOLOGY, cilt.43, ss.524-529, 2016
dc.identifier.issn0315-162X
dc.identifier.othervv_1032021
dc.identifier.otherav_c85bd0e4-3af4-44ed-8714-a10c3d2d060b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/132777
dc.identifier.urihttps://doi.org/10.3899/jrheum.150177
dc.description.abstractObjective. Screening strategies for latent tuberculosis (TB) before starting tumor necrosis factor (TNF)-alpha inhibitors have decreased the prevalence of TB among patients who are treated with these agents. However, despite vigilant screening, TB continues to be an important problem, especially in parts of the world with a high background TB prevalence. The aim of this study was to determine the factors related to TB among a large multicenter cohort of patients who were treated with anti-TNF.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectİç Hastalıkları
dc.subjectİmmünoloji ve Romatoloji
dc.subjectROMATOLOJİ
dc.subjectDahili Tıp Bilimleri
dc.subjectKlinik Tıp
dc.titleCharacteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-alpha Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence
dc.typeMakale
dc.relation.journalJOURNAL OF RHEUMATOLOGY
dc.contributor.departmentEge Üniversitesi , ,
dc.identifier.volume43
dc.identifier.issue3
dc.identifier.startpage524
dc.identifier.endpage529
dc.contributor.firstauthorID51381


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster